News
4d
Week99er on MSNRetatrutide (LY3437943): A Comprehensive Review of Its Therapeutic Potential in Obesity and Type 2 Diabetes MellitusThe escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...
Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...
2d
News-Medical.Net on MSNGLP-1 agonists may reshape the gut microbiomeResearch reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...
As diabetes cases soar in the US, physicians are sounding the alarm, especially in economically challenged regions. The push ...
Compounded semaglutide helps manage blood sugar and curb appetite for better diabetes control and weight loss. Learn how it ...
Type 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals ...
Diabetes medications, including a popular weight loss drug, are offering new hope for more than 400,000 Australians living with dementia. Promising research published in the JAMA Neurology finds newer ...
Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results